Environmental Controls & Personal Protection to Reduce the Risk of Infection In addition to administrative controls, environment controls and personal protection [32] are also essential in reducing ...

Breast tuberculosis, a rare form of extrapulmonary tuberculosis, represents a diagnostic challenge due to its nonspecific clinical and imaging features that can mimic both benign and malignant breast ...

KARACHI, March 21: Healthcare providers need to be urgently educated about proper tuberculosis management particularly regarding mild to severe side effects of anti-TB drugs. This was discussed in a ...

The American Thoracic Society (ATS), the U.S. Centers for Disease Control and Prevention (CDC), and the Infectious Diseases Society of American (IDSA) announce the release of the first completely ...

One in five multi-drug resistant (MDR) tuberculosis (TB) cases in children under the age of 15 could be averted every year by household contact management, according to a new modeling study published ...

Tuberculosis (TB) remains a global health challenge, affecting millions each year. In 2023, an estimated 10.8 million people contracted TB, with 1.25 million deaths, according to the World Health ...

In a recent study published in the journal Clinical Infectious Diseases, researchers reported on the treatment of rifampin-resistant tuberculosis in the United States (U.S.) using the Food and Drug ...

Launch of QIAseq xHYB Mycobacterium tuberculosis Panel for research use, enabling culture-free whole genome sequencing from complex samples // Panel significantly accelerates TB outbreak tracking and ...

Bangkok, Thailand Tuesday, February 10, 2026, 16:00 Hrs [IST] ...

A significant proportion of people in the community with pulmonary tuberculosis (TB) have subclinical disease, according to a meta-analysis involving survey studies across Africa and Asia. In adjusted ...

Extensive drug resistance in TB is not a new phenomenon. It is created when patients with multidrug-resistant TB (MDR-TB) are treated with second-line anti-TB drugs but fail to be cured. The first ...